GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
67.33
-0.40 (-0.59%)
At close: Oct 9, 2026, 4:00 PM EDT
67.33
0.00 (0.00%)
After-hours: Oct 9, 2026, 4:38 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.01 billion as of October 9, 2026. It is the 6,694th most valuable company in the world and the 1,762nd biggest in the United States. Its market cap has decreased by 43.03% in one year.
Market Cap
2.01B
Enterprise Value
2.04B
1-Year Change
-43.03%
Global Rank
Country Rank
#1,762 United States
Category
ChartMarket Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.01B, a decrease of -88.78%. That is a compound annual growth rate of -30.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.01B | -46.59% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RadNet | 5.53B |
| Sotera Health Company | 5.21B |
| BillionToOne | 4.72B |
| Adaptive Biotechnologies | 4.29B |
| Veracyte | 3.59B |
| CareDx | 3.30B |
| NeoGenomics | 2.12B |
| Freenome | 1.76B |